- Home
- EXEL vs PCOR Comparison
EXEL vs PCOR Comparison
Compare EXEL & PCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | PCOR |
|---|---|---|
| Founded | 1994 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.3B |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EXEL | PCOR |
|---|---|---|
| Price | $44.37 | $77.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 18 |
| Target Price | $44.73 | ★ $83.06 |
| AVG Volume (30 Days) | ★ 2.5M | 1.3M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $2,288,218,000.00 | $1,275,450,000.00 |
| Revenue This Year | $9.14 | $16.35 |
| Revenue Next Year | $12.51 | $12.09 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | 9.93 | ★ 14.94 |
| 52 Week Low | $31.90 | $53.71 |
| 52 Week High | $49.62 | $88.92 |
Technical Indicators
Market Signals| Indicator | EXEL | PCOR |
|---|---|---|
| Relative Strength Index (RSI) | 63.52 | 60.44 |
| Support Level | $43.00 | $74.36 |
| Resistance Level | $44.79 | $76.70 |
| Average True Range (ATR) | 1.03 | 2.51 |
| MACD | 0.06 | 0.37 |
| Stochastic Oscillator | 83.48 | 92.58 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.